These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 1987060
1. Immunological characterization of Clostridium butyricum neurotoxin and its trypsin-induced fragment by use of monoclonal antibodies against Clostridium botulinum type E neurotoxin. Kozaki S, Onimaru J, Kamata Y, Sakaguchi G. Infect Immun; 1991 Jan; 59(1):457-9. PubMed ID: 1987060 [Abstract] [Full Text] [Related]
2. Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids. Kozaki S, Ogasawara J, Shimote Y, Kamata Y, Sakaguchi G. Infect Immun; 1987 Dec; 55(12):3051-6. PubMed ID: 2824382 [Abstract] [Full Text] [Related]
3. Comparative molecular topography of botulinum neurotoxins from Clostridium butyricum and Clostridium botulinum type E. Singh BR, Giménez JA, DasGupta BR. Biochim Biophys Acta; 1991 Mar 08; 1077(1):119-26. PubMed ID: 1901221 [Abstract] [Full Text] [Related]
4. The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin. Kozaki S, Kamata Y, Nagai T, Ogasawara J, Sakaguchi G. Infect Immun; 1986 Jun 08; 52(3):786-91. PubMed ID: 2423459 [Abstract] [Full Text] [Related]
5. Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes. Kozaki S, Miki A, Kamata Y, Ogasawara J, Sakaguchi G. Infect Immun; 1989 Sep 08; 57(9):2634-9. PubMed ID: 2668181 [Abstract] [Full Text] [Related]
6. Clostridium butyricum neurotoxin: partial amino acid sequence of major proteolytic fragments and intracellular activity in PC12 cells. Giménez J, Lomneth R, DasGupta BR. Toxicon; 1994 Sep 08; 32(9):1137-46. PubMed ID: 7801349 [Abstract] [Full Text] [Related]
7. Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity. Shone CC, Hambleton P, Melling J. Eur J Biochem; 1985 Aug 15; 151(1):75-82. PubMed ID: 3896784 [Abstract] [Full Text] [Related]
8. Immunological characterization of the neurotoxin produced by Clostridium botulinum type A associated with infant botulism in Japan. Kozaki S, Nakaue S, Kamata Y. Microbiol Immunol; 1995 Aug 15; 39(10):767-74. PubMed ID: 8577267 [Abstract] [Full Text] [Related]
9. Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E. Bever CS, Scotcher M, Cheng LW, Hnasko RM, Stanker LH. Toxins (Basel); 2019 Jul 13; 11(7):. PubMed ID: 31337022 [Abstract] [Full Text] [Related]
10. Botulinum neurotoxin type A: cleavage of the heavy chain into two halves and their partial sequences. Sathyamoorthy V, Dasgupta BR, Foley J, Niece RL. Arch Biochem Biophys; 1988 Oct 13; 266(1):142-51. PubMed ID: 3178218 [Abstract] [Full Text] [Related]
15. Purification and characterization of neurotoxin produced by Clostridium botulinum type C 6813. Terajima J, Syuto B, Ochanda JO, Kubo S. Infect Immun; 1985 May 13; 48(2):312-7. PubMed ID: 3988338 [Abstract] [Full Text] [Related]